The Trans-Pacific Health Sciences Dialogue is a meeting for biopharmaceutical industry executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.

Over the course of two days, executives, dealmakers, investors, professional advisors and KOLs with deep Trans-Pacific experience will share their insights and experiences in an intimate and collegial setting that encourages interaction and collaboration. The program features informative panel discussions and case studies that focus on best practices to create growth, achieve objectives, add value and minimize risk on both sides of the Pacific.

The Health Sciences Dialogue is a must-attend meeting for executives whose strategy includes establishing a Trans-Pacific collaboration or investment. Attendees will come away with a broad overview and insights that they simply will not get in other meetings.


Now in its fifteenth year, the Health Sciences Dialogue event was established by the Japan America Society of Greater Philadelphia to improve the productivity of partnerships between Asian and North American biopharmaceutical companies and their stakeholders.


The Trans-Pacific Health Sciences Dialogue is organized by Demy-Colton Life Science Advisors.


Demy-Colton Life Science Advisors is not affiliated with Harvard University, nor is the “Trans- Pacific Health Sciences Dialogue” a Harvard University program or activity.